| Mr Mark John Piotrowski, MD | |
|
1100 W Central Rd, Suite 205, Arlington Heights, IL 60005 | |
| (847) 253-4040 | |
| (847) 253-3028 |
| Full Name | Mr Mark John Piotrowski |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 25 Years |
| Location | 1100 W Central Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417059114 | NPI | - | NPPES |
| 01623492 | Other | IL | BCBS |
| 571890 | Other | IL | MEDICARE GROUP NUMBER |
| 036108737 | Medicaid | IL | |
| K00008 | Other | IL | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 036108737 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Alexius Medical Center | Hoffman estates, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Suburban Associates In Ophthalmology Llc | 5294740320 | 8 |
News Archive
A new paper by vascular surgeons at the University of Miami Miller School of Medicine, published in the Journal of Vascular Surgery, describes how thrombosis (blood clots in the circulatory system) was an early indication of infection in a COVID-19 patient.
Lundbeck Inc. today announced the presentation of results from an open-label extension study of Xenazine- (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Data from this study demonstrated that after an 80-week treatment period, subjects treated with Xenazine experienced a statistically significant reduction in chorea score (p< 0.0001) as measured using the Unified Huntington's Disease Rating Scale (UHDRS) compared with baseline.
Drug discovery and development company SCYNEXIS, Inc. today announced that the Company has been awarded four grants totaling $977,917 under the U.S. Federal Government's Qualifying Therapeutic Discovery Project (QTDP). SCYNEXIS is developing a proprietary internal pipeline of cyclophilin inhibitors, a class of drugs that hold significant potential for the treatment of a broad range of diseases.
A study led by Kevin King, a bioengineer and physician at the University of California San Diego, has found that the immune system plays a surprising role in the aftermath of heart attacks. The research could lead to new therapeutic strategies for heart disease.
Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology. Researchers said the technique also could improve patient management by differentiating high-risk lesions requiring additional workup from other non-malignant subtypes.
› Verified 5 days ago
| Entity Name | Suburban Associates In Ophthalmology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316032337 PECOS PAC ID: 5294740320 Enrollment ID: O20060210000525 |
News Archive
A new paper by vascular surgeons at the University of Miami Miller School of Medicine, published in the Journal of Vascular Surgery, describes how thrombosis (blood clots in the circulatory system) was an early indication of infection in a COVID-19 patient.
Lundbeck Inc. today announced the presentation of results from an open-label extension study of Xenazine- (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Data from this study demonstrated that after an 80-week treatment period, subjects treated with Xenazine experienced a statistically significant reduction in chorea score (p< 0.0001) as measured using the Unified Huntington's Disease Rating Scale (UHDRS) compared with baseline.
Drug discovery and development company SCYNEXIS, Inc. today announced that the Company has been awarded four grants totaling $977,917 under the U.S. Federal Government's Qualifying Therapeutic Discovery Project (QTDP). SCYNEXIS is developing a proprietary internal pipeline of cyclophilin inhibitors, a class of drugs that hold significant potential for the treatment of a broad range of diseases.
A study led by Kevin King, a bioengineer and physician at the University of California San Diego, has found that the immune system plays a surprising role in the aftermath of heart attacks. The research could lead to new therapeutic strategies for heart disease.
Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology. Researchers said the technique also could improve patient management by differentiating high-risk lesions requiring additional workup from other non-malignant subtypes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mark John Piotrowski, MD 1100 W Central Rd, Suite 205, Arlington Heights, IL 60005 Ph: (847) 253-4040 | Mr Mark John Piotrowski, MD 1100 W Central Rd, Suite 205, Arlington Heights, IL 60005 Ph: (847) 253-4040 |
News Archive
A new paper by vascular surgeons at the University of Miami Miller School of Medicine, published in the Journal of Vascular Surgery, describes how thrombosis (blood clots in the circulatory system) was an early indication of infection in a COVID-19 patient.
Lundbeck Inc. today announced the presentation of results from an open-label extension study of Xenazine- (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Data from this study demonstrated that after an 80-week treatment period, subjects treated with Xenazine experienced a statistically significant reduction in chorea score (p< 0.0001) as measured using the Unified Huntington's Disease Rating Scale (UHDRS) compared with baseline.
Drug discovery and development company SCYNEXIS, Inc. today announced that the Company has been awarded four grants totaling $977,917 under the U.S. Federal Government's Qualifying Therapeutic Discovery Project (QTDP). SCYNEXIS is developing a proprietary internal pipeline of cyclophilin inhibitors, a class of drugs that hold significant potential for the treatment of a broad range of diseases.
A study led by Kevin King, a bioengineer and physician at the University of California San Diego, has found that the immune system plays a surprising role in the aftermath of heart attacks. The research could lead to new therapeutic strategies for heart disease.
Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology. Researchers said the technique also could improve patient management by differentiating high-risk lesions requiring additional workup from other non-malignant subtypes.
› Verified 5 days ago
Dr. David Y. Badawi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3030 Salt Creek Lane, Suite 300, Arlington Heights, IL 60005 Phone: 847-978-4535 Fax: 847-960-5378 | |
Gregory Nelson, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1100 W Central Rd, Suite 205, Arlington Heights, IL 60005 Phone: 847-253-4040 Fax: 847-253-3028 | |
Ostap Nykyfor Kashuba, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 W Central Road, Suite 205, Arlington Heights, IL 60005 Phone: 847-253-4040 Fax: 847-253-3028 | |
Oussama Boundaoui, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1211 S Arlington Heights Rd, Arlington Heights, IL 60005 Phone: 847-264-2222 Fax: 847-437-6841 | |
Mrs. Janet Zeiler Bresch, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1100 W Central Rd, Suite 205, Arlington Heights, IL 60005 Phone: 847-253-4040 Fax: 847-253-3028 | |
Dr. Adam Lee Prickett, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1588 N Arlington Heights Rd, Arlington Heights, IL 60004 Phone: 847-392-9220 Fax: 847-392-9252 | |
Smajo S Osmanovic, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1604 W Central Rd, Arlington Heights, IL 60005 Phone: 847-394-1414 Fax: 847-394-5380 |